Status | Study |
Completed |
Study Name: Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA Condition: Clear Cell Renal Cell Carcinoma Date: 2015-11-16 Interventions: Drug: G-202 G-202 administered by intravenous infusion on Days 1, 2 and 3 of each 28-day cycle until dis |
Recruiting |
Study Name: Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma Condition: Clear Cell Renal Cell Carcinoma Date: 2015-10-06 Interventions: Drug: Nivolumab 3 mg/kg, IV (in the vein) on day 1 of each 2-week cycle, for a total of 3 doses prior to |
Recruiting |
Study Name: SLM + Axitinib for Clear Cell RCC Condition: Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) Date: 2015-08-17 Interventions: Drug: Selenomethionine (SLM) S |
Recruiting |
Study Name: A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma Condition: ccRCC RCC Kidney Cancer Date: 2014-11-14 Interventions: Drug: PART 1: PT2385 Tablets P |
Completed |
Study Name: Investigating Patient Satisfaction With Oral Anti-Cancer Treatment Condition: Clear Cell Renal Cell Carcinoma Date: 2014-07-03 |
Completed |
Study Name: Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer Condition: Metastatic Clear Cell Renal Cell Carcinoma Date: 2013-11-29 Interventions: Drug: Lu-177-DOTA-girentuximab Drug: In-111-DOTA-girentuxi |
Completed |
Study Name: Value of Various Chemokines in the Detection and Follow up of RCC Condition: Clear Cell Renal Cell Carcinoma Date: 2013-10-30 Interventions: Other: patients with renal cell carcinoma Chemokines that may be elevated in patients with RCC |
Recruiting |
Study Name: High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer Condition: Metastatic Clear Cell Renal Cell Carcinoma Date: 2013-07-05 Interventions: Drug: IL-2 HD IL-2 (brand name |
Completed |
Study Name: 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC Condition: Clear Cell Renal Cell Carcinoma Date: 2013-01-08 Interventions: Drug: Dovitinib Patients will be treated with dovitinib (5 |
Recruiting |
Study Name: Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer Condition: Clear Cell Renal Cell Carcinoma Stage IV Renal Cell Cancer Date: 2012-08-24 Interventions: Biological: Bevacizumab Given |